Haiming Xiao

647 total citations
23 papers, 473 citations indexed

About

Haiming Xiao is a scholar working on Molecular Biology, Clinical Biochemistry and Oncology. According to data from OpenAlex, Haiming Xiao has authored 23 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 5 papers in Clinical Biochemistry and 3 papers in Oncology. Recurrent topics in Haiming Xiao's work include Connexins and lens biology (5 papers), Advanced Glycation End Products research (5 papers) and Heme Oxygenase-1 and Carbon Monoxide (4 papers). Haiming Xiao is often cited by papers focused on Connexins and lens biology (5 papers), Advanced Glycation End Products research (5 papers) and Heme Oxygenase-1 and Carbon Monoxide (4 papers). Haiming Xiao collaborates with scholars based in China, India and Singapore. Haiming Xiao's co-authors include Zeyuan Lin, Yan Yang, Heqing Huang, Peiqing Liu, Meng Zhang, Zhanchi Xu, Xiaohong Sun, Zhiquan Chen, Heqing Huang and Shijian Quan and has published in prestigious journals such as British Journal of Pharmacology, Biochemical Pharmacology and Experimental Cell Research.

In The Last Decade

Haiming Xiao

23 papers receiving 473 citations

Peers

Haiming Xiao

NEPHR

EPIDE

PHYSI

Zeyuan Lin China

Meili Yang China

Zhimin Mao China

Zi-Yue Wan China

Wenqi Li China

Ling Guo China

Yan‐Zi Yang China

Yangyang Wang China

Shunmin Li China

Zeyuan Lin China

Haiming Xiao

258 ×1.0

78 ×1.1

NEPHR

64 ×1.0

EPIDE

52 ×1.0

39 ×0.8

PHYSI

Citations per year, relative to Haiming Xiao Haiming Xiao (= 1×) peers Zeyuan Lin

Countries citing papers authored by Haiming Xiao

Since Specialization

Citations

This map shows the geographic impact of Haiming Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiming Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiming Xiao more than expected).

Fields of papers citing papers by Haiming Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiming Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiming Xiao. The network helps show where Haiming Xiao may publish in the future.

Co-authorship network of co-authors of Haiming Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Haiming Xiao. A scholar is included among the top collaborators of Haiming Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiming Xiao. Haiming Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Shanshan, Haiming Xiao, Xuting Zhang, et al.. (2025). Reynoutrin activates Sirt1/Foxo3a and Nrf2 pathway via targeting Fyn to ameliorate diabetic nephropathy. Phytomedicine. 146. 157158–157158. 1 indexed citations

Li, Minghui, Haiming Xiao, Shanshan Li, et al.. (2024). Cinnamaldehyde activates AMPK/PGC-1α pathway via targeting GRK2 to ameliorate heart failure. Phytomedicine. 133. 155894–155894. 9 indexed citations

Liáng, Lìyı̌n, Renbin Liu, Xuting Zhang, et al.. (2024). Polydatin attenuates diabetic renal inflammatory fibrosis via the inhibition of STING pathway. Biochemical Pharmacology. 226. 116373–116373. 6 indexed citations

Xu, Zhanchi, Minghui Li, Haiming Xiao, et al.. (2024). Xinbao Pill ameliorates heart failure via regulating the SGLT1/AMPK/PPARα axis to improve myocardial fatty acid energy metabolism. Chinese Medicine. 19(1). 82–82. 7 indexed citations

Xu, Zhanchi, et al.. (2024). Gentiopicroside ameliorates glucose and lipid metabolism in T2DM via targeting FGFR1. Phytomedicine. 132. 155780–155780. 11 indexed citations

Zhang, Xuting, Shanshan Li, Haiming Xiao, et al.. (2024). Discovery of a SUCNR1 antagonist for potential treatment of diabetic nephropathy: In silico and in vitro studies. International Journal of Biological Macromolecules. 268(Pt 2). 131898–131898. 3 indexed citations

Li, Shanshan, Haiming Xiao, Xiaohong Sun, et al.. (2023). Connexin32 Promotes the Activation of Foxo3a to Ameliorate Diabetic Nephropathy via Inhibiting the Polyubiquitination and Degradation of Sirt1. Antioxidants and Redox Signaling. 39(4-6). 241–261. 5 indexed citations

Lin, Zeyuan, Shanshan Li, Haiming Xiao, et al.. (2023). The degradation of TGR5 mediated by Smurf1 contributes to diabetic nephropathy. Cell Reports. 42(8). 112851–112851. 9 indexed citations

Yang, Yan, Haiming Xiao, Zeyuan Lin, et al.. (2022). The ubiquitination of CKIP-1 mediated by Src aggravates diabetic renal fibrosis (original article). Biochemical Pharmacology. 206. 115339–115339. 11 indexed citations

10.

Sun, Xiaohong, Haiming Xiao, Rui Chen, et al.. (2022). Connexin32 ameliorates epithelial-to-mesenchymal-transition in diabetic renal tubular via inhibiting NOX4. Pharmacological Research. 176. 106084–106084. 6 indexed citations

11.

Chen, Rui, Haiming Xiao, Shanshan Li, et al.. (2022). Fraxin Promotes the Activation of Nrf2/ARE Pathway via Increasing the Expression of Connexin43 to Ameliorate Diabetic Renal Fibrosis. Frontiers in Pharmacology. 13. 853383–853383. 11 indexed citations

12.

Li, Shanshan, Zeyuan Lin, Haiming Xiao, et al.. (2022). Fyn deficiency inhibits oxidative stress by decreasing c-Cbl-mediated ubiquitination of Sirt1 to attenuate diabetic renal fibrosis. Metabolism. 139. 155378–155378. 31 indexed citations

13.

Sun, Xiaohong, Haiming Xiao, Meng Zhang, et al.. (2021). USP9X deubiquitinates connexin43 to prevent high glucose-induced epithelial-to-mesenchymal transition in NRK-52E cells. Biochemical Pharmacology. 188. 114562–114562. 23 indexed citations

14.

Yang, Yan, Jie Li, Lingqiang Zhang, et al.. (2020). CKIP-1 acts downstream to Cx43 on the activation of Nrf2 signaling pathway to protect from renal fibrosis in diabetes. Pharmacological Research. 163. 105333–105333. 11 indexed citations

15.

Li, Xuejuan, Zhanchi Xu, Yan Yang, et al.. (2020). Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway. Acta Pharmacologica Sinica. 41(12). 1587–1596. 37 indexed citations

16.

Chen, Zhiquan, Xiaohong Sun, Qiuhong Chen, et al.. (2019). Connexin32 ameliorates renal fibrosis in diabetic mice by promoting K48‐linked NADPH oxidase 4 polyubiquitination and degradation. British Journal of Pharmacology. 177(1). 145–160. 24 indexed citations

17.

Xiao, Haiming, Xiaohong Sun, Renbin Liu, et al.. (2019). Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy. Pharmacological Research. 151. 104559–104559. 85 indexed citations

18.

Sun, Xiaohong, Haiming Xiao, Yan Yang, et al.. (2019). PAQR3 regulates phosphorylation of FoxO1 in insulin-resistant HepG2 cells via NF-κB signaling pathway. Experimental Cell Research. 381(2). 301–310. 18 indexed citations

19.

Xiao, Haiming, Renbin Liu, Yan Yang, et al.. (2019). Paeonol Ameliorates Glucose and Lipid Metabolism in Experimental Diabetes by Activating Akt. Frontiers in Pharmacology. 10. 261–261. 26 indexed citations

20.

Xiao, Haiming & Yuming Jiang. (2004). Analysis of Multi-Server Round Robin Scheduling Disciplines. IEICE Transactions on Communications. 87(12). 3593–3602. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact